Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -145.12%-19.35K | 76.81%-17.21K | 91.32%-3.59K | 96.87%-925 | -94.26%-4.81K | -802.06%-7.89K | -0.21%-74.23K | -244.89%-41.3K | -87.65%-29.57K | 79.19%-2.48K |
| Net income from continuing operations | 17.55%-12.17K | -8.19%-78.28K | -6.46%-26.76K | -25.04%-17.61K | -9.55%-19.15K | 5.70%-14.76K | -2.33%-72.36K | 12.28%-25.14K | -2.64%-14.08K | -2.38%-17.48K |
| Asset impairment expenditure | --0 | -10.15%2.53K | -4.07%471 | -5.68%1.08K | -11.80%523 | -22.28%457 | -4.35%2.82K | -35.22%491 | 45.86%1.15K | -12.15%593 |
| Deferred tax | ---- | 10.15%-2.53K | ---- | ---- | ---- | ---- | ---2.82K | ---- | ---- | ---- |
| Other non cashItems | 11.83%5.13K | 68.02%18.85K | 15.13%4.83K | 80.51%4.7K | 111.72%4.73K | 109.97%4.59K | 108.59%11.22K | 116.18%4.2K | 55.19%2.6K | 71.79%2.24K |
| Change In working capital | -775.58%-12.31K | 422.67%42.22K | 213.11%20.4K | 156.72%10.91K | -25.38%9.09K | -84.82%1.82K | -12.03%-13.09K | -229.02%-18.04K | -327.52%-19.23K | 279.59%12.18K |
| -Change in prepaid assets | --0 | 290.83%1.1K | --0 | --0 | --552 | 4.95%551 | -2,212.00%-578 | 4.94%552 | -415.24%-1.66K | --0 |
| -Change in payables and accrued expense | -1,068.45%-12.31K | 428.76%41.12K | 209.75%20.4K | 162.06%10.91K | -29.91%8.54K | -88.93%1.27K | -7.31%-12.51K | -238.16%-18.59K | -249.90%-17.58K | 154.57%12.18K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -145.12%-19.35K | 76.81%-17.21K | 91.32%-3.59K | 96.87%-925 | -94.26%-4.81K | -802.06%-7.89K | -0.21%-74.23K | -244.89%-41.3K | -87.65%-29.57K | 79.19%-2.48K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 319.05%22K | -82.34%13.75K | -90.70%4K | -96.88%1K | 40.00%3.5K | 1,400.00%5.25K | 8.13%77.85K | 258.33%43K | 113.33%32K | -75.00%2.5K |
| Net issuance payments of debt | 319.05%22K | -82.34%13.75K | -90.70%4K | -96.88%1K | 40.00%3.5K | 1,400.00%5.25K | 8.13%77.85K | 258.33%43K | 113.33%32K | -75.00%2.5K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 319.05%22K | -82.34%13.75K | -90.70%4K | -96.88%1K | 40.00%3.5K | 1,400.00%5.25K | 8.13%77.85K | 258.33%43K | 113.33%32K | -75.00%2.5K |
| Net cash flow | ||||||||||
| Beginning cash position | -82.68%725 | 646.17%4.19K | -87.55%310 | 285.25%235 | 4,186.11%1.54K | 646.17%4.19K | -78.64%561 | 363.69%2.49K | -95.29%61 | -98.87%36 |
| Current changes in cash | 200.38%2.65K | -195.48%-3.46K | -75.53%415 | -96.91%75 | -5,332.00%-1.31K | -403.43%-2.64K | 275.46%3.63K | 6,966.67%1.7K | 420.03%2.43K | 101.32%25 |
| End cash Position | 118.92%3.38K | -82.68%725 | -82.68%725 | -87.55%310 | 285.25%235 | 4,186.11%1.54K | 646.17%4.19K | 646.17%4.19K | 363.69%2.49K | -95.29%61 |
| Free cash from | -145.12%-19.35K | 76.81%-17.21K | 91.32%-3.59K | 96.87%-925 | -94.26%-4.81K | -802.06%-7.89K | -0.21%-74.23K | -244.89%-41.3K | -87.65%-29.57K | 79.19%-2.48K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.